Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Influenza

  Free Subscription


Articles published in J Virol

Retrieve available abstracts of 302 articles:
HTML format



Single Articles


    June 2022
  1. CHRISTENSEN SR, Martin ET, Petrie JG, Monto AS, et al
    The 2009 Pandemic H1N1 Hemagglutinin Stalk Remained Antigenically Stable after Circulating in Humans for a Decade.
    J Virol. 2022;96:e0220021.
    PubMed     Abstract available


  2. SCHEIBNER D, Breithaupt A, Luttermann C, Blaurock C, et al
    Genetic Determinants for Virulence and Transmission of the Panzootic Avian Influenza Virus H5N8 Clade 2.3.4.4 in Pekin Ducks.
    J Virol. 2022 Jun 7:e0014922. doi: 10.1128/jvi.00149.
    PubMed     Abstract available


  3. LIU H, Bai Y, Zhang X, Gao T, et al
    SARS-CoV-2 N Protein Antagonizes Stress Granule Assembly and IFN Production by Interacting with G3BPs to Facilitate Viral Replication.
    J Virol. 2022 Jun 2:e0041222. doi: 10.1128/jvi.00412.
    PubMed     Abstract available


    May 2022
  4. PRICE GE, Lo CY, Misplon JA, Epstein SL, et al
    Reduction of Influenza A Virus Transmission in Mice by a Universal Intranasal Vaccine Candidate is Long-Lasting and Does Not Require Antibodies.
    J Virol. 2022 May 31:e0032022. doi: 10.1128/jvi.00320.
    PubMed     Abstract available


  5. ZHENG H, Ma L, Gui R, Lin X, et al
    G Protein Subunit beta1 Facilitates Influenza A Virus Replication by Promoting the Nuclear Import of PB2.
    J Virol. 2022 May 23:e0049422. doi: 10.1128/jvi.00494.
    PubMed     Abstract available


  6. VANDOORN E, Stadejek W, Parys A, Chepkwony S, et al
    Pathobiology of an NS1-Truncated H3N2 Swine Influenza Virus Strain in Pigs.
    J Virol. 2022 May 12:e0051922. doi: 10.1128/jvi.00519.
    PubMed     Abstract available


  7. NCHIOUA R, Schundner A, Kmiec D, Prelli Bozzo C, et al
    SARS-CoV-2 Variants of Concern Hijack IFITM2 for Efficient Replication in Human Lung Cells.
    J Virol. 2022 May 11:e0059422. doi: 10.1128/jvi.00594.
    PubMed     Abstract available


    April 2022
  8. DIEFENBACHER M, Tan TJC, Bauer DLV, Stadtmueller BM, et al
    Interactions between Influenza A Virus Nucleoprotein and Gene Segment Untranslated Regions Facilitate Selective Modulation of Viral Gene Expression.
    J Virol. 2022 Apr 25:e0020522. doi: 10.1128/jvi.00205.
    PubMed     Abstract available


  9. ROACH SN, Fiege JK, Shepherd FK, Wiggen TD, et al
    Respiratory Influenza Virus Infection Causes Dynamic Tuft Cell and Innate Lymphoid Cell Changes in the Small Intestine.
    J Virol. 2022 Apr 21:e0035222. doi: 10.1128/jvi.00352.
    PubMed     Abstract available


  10. KIRKPATRICK ROUBIDOUX E, Sano K, McMahon M, Carreno JM, et al
    Novel Epitopes of the Influenza Virus N1 Neuraminidase Targeted by Human Monoclonal Antibodies.
    J Virol. 2022 Apr 21:e0033222. doi: 10.1128/jvi.00332.
    PubMed     Abstract available


  11. ZHENG XS, Wang Q, Min J, Shen XR, et al
    Single-Cell Landscape of Lungs Reveals Key Role of Neutrophil-Mediated Immunopathology during Lethal SARS-CoV-2 Infection.
    J Virol. 2022 Apr 14:e0003822. doi: 10.1128/jvi.00038.
    PubMed     Abstract available


  12. RAJAN A, Piedra FA, Aideyan L, McBride T, et al
    Multiple Respiratory Syncytial Virus (RSV) Strains Infecting HEp-2 and A549 Cells Reveal Cell Line-Dependent Differences in Resistance to RSV Infection.
    J Virol. 2022;96:e0190421.
    PubMed     Abstract available


  13. NUNEZ CASTREJON AM, O'Rourke SM, Kauvar LM, DuBois RM, et al
    Structure-Based Design and Antigenic Validation of Respiratory Syncytial Virus G Immunogens.
    J Virol. 2022;96:e0220121.
    PubMed     Abstract available


  14. DESCHAMBAULT Y, Lynch J, Warner B, Tierney K, et al
    Single Immunization with Recombinant ACAM2000 Vaccinia Viruses Expressing the Spike and the Nucleocapsid Proteins Protects Hamsters against SARS-CoV-2-Caused Clinical Disease.
    J Virol. 2022 Apr 12:e0038922. doi: 10.1128/jvi.00389.
    PubMed     Abstract available


  15. BAO D, Lu C, Ma T, Xu G, et al
    Hydrophobic Residues at the Intracellular Domain of the M2 Protein Play an Important Role in Budding and Membrane Integrity of Influenza Virus.
    J Virol. 2022 Apr 11:e0037322. doi: 10.1128/jvi.00373.
    PubMed     Abstract available


  16. CHEN J, Li Z, Guo J, Xu S, et al
    SARS-CoV-2 nsp5 Exhibits Stronger Catalytic Activity and Interferon Antagonism than Its SARS-CoV Ortholog.
    J Virol. 2022 Apr 7:e0003722. doi: 10.1128/jvi.00037.
    PubMed     Abstract available


  17. FARIAS JP, da Silva PS, Fogaca MMC, Santana IVR, et al
    The COVID-19 Humoral Immunological Status Induced by CoronaVac and AstraZeneca Vaccines Significantly Benefits from a Booster Shot with the Pfizer Vaccine.
    J Virol. 2022 Apr 7:e0017722. doi: 10.1128/jvi.00177.
    PubMed     Abstract available


  18. LI J, Lin C, Zhou X, Zhong F, et al
    Structural Basis of the Main Proteases of Coronavirus Bound to Drug Candidate PF-07321332.
    J Virol. 2022 Apr 7:e0201321. doi: 10.1128/jvi.02013.
    PubMed     Abstract available


  19. KLASSE PJ, Moore JP
    Reappraising the Value of HIV-1 Vaccine Correlates of Protection Analyses.
    J Virol. 2022 Apr 6:e0003422. doi: 10.1128/jvi.00034.
    PubMed     Abstract available


  20. LIU X, Zheng L, Wang T, Li Y, et al
    A System Based on Novel Parainfluenza Virus PIV5-L for Efficient Gene Delivery of B-Lymphoma Cells.
    J Virol. 2022 Apr 4:e0025722. doi: 10.1128/jvi.00257.
    PubMed     Abstract available


    March 2022
  21. HANCOCK TJ, Hickman P, Kazerooni N, Kennedy M, et al
    Possible Cross-Reactivity of Feline and White-Tailed Deer Antibodies against the SARS-CoV-2 Receptor Binding Domain.
    J Virol. 2022 Mar 30:e0025022. doi: 10.1128/jvi.00250.
    PubMed     Abstract available


  22. ESSALMANI R, Jain J, Susan-Resiga D, Andreo U, et al
    Distinctive Roles of Furin and TMPRSS2 in SARS-CoV-2 Infectivity.
    J Virol. 2022 Mar 28:e0012822. doi: 10.1128/jvi.00128.
    PubMed     Abstract available


  23. GENG Q, Shi K, Ye G, Zhang W, et al
    Structural Basis for Human Receptor Recognition by SARS-CoV Omicron Variant BA.1.
    J Virol. 2022 Mar 28:e0024922. doi: 10.1128/jvi.00249.
    PubMed     Abstract available


  24. LIU MQ, Jiang RD, Guo J, Chen Y, et al
    Inactivated SARS-CoV-2 Vaccine Shows Cross-Protection against Bat SARS-Related Coronaviruses in Human ACE2 Transgenic Mice.
    J Virol. 2022 Mar 28:e0016922. doi: 10.1128/jvi.00169.
    PubMed     Abstract available


  25. XIANG J, Lu M, Shi M, Cheng X, et al
    Heparanase Blockade as a Novel Dual-Targeting Therapy for COVID-19.
    J Virol. 2022 Mar 23:e0005722. doi: 10.1128/jvi.00057.
    PubMed     Abstract available


  26. JIANG L, Samant N, Liu P, Somasundaran M, et al
    Identification of a Permissive Secondary Mutation That Restores the Enzymatic Activity of Oseltamivir Resistance Mutation H275Y.
    J Virol. 2022;96:e0198221.
    PubMed     Abstract available


  27. LI Y, Liu S, Chen Y, Chen B, et al
    Syk Facilitates Influenza A Virus Replication by Restraining Innate Immunity at the Late Stage of Viral Infection.
    J Virol. 2022 Mar 16:e0020022. doi: 10.1128/jvi.00200.
    PubMed     Abstract available


  28. BERKHOUT B, Herrera-Carrillo E
    SARS-CoV-2 Evolution: On the Sudden Appearance of the Omicron Variant.
    J Virol. 2022 Mar 16:e0009022. doi: 10.1128/jvi.00090.
    PubMed     Abstract available


  29. GAO J, Tang YD, Hu W, Zheng C, et al
    When Poly(A) Binding Proteins Meet Viral Infections, Including SARS-CoV-2.
    J Virol. 2022 Mar 16:e0013622. doi: 10.1128/jvi.00136.
    PubMed     Abstract available


  30. ALLEN JD, Ross TM
    Bivalent H1 and H3 COBRA Recombinant Hemagglutinin Vaccines Elicit Seroprotective Antibodies against H1N1 and H3N2 Influenza Viruses from 2009 to 2019.
    J Virol. 2022 Mar 15:e0165221. doi: 10.1128/jvi.01652.
    PubMed     Abstract available


  31. METZ-ZUMARAN C, Kee C, Doldan P, Guo C, et al
    Increased Sensitivity of SARS-CoV-2 to Type III Interferon in Human Intestinal Epithelial Cells.
    J Virol. 2022 Mar 9:e0170521. doi: 10.1128/jvi.01705.
    PubMed     Abstract available


  32. HU M, Jones JC, Banoth B, Ojha CR, et al
    Swine H1N1 Influenza Virus Variants with Enhanced Polymerase Activity and HA Stability Promote Airborne Transmission in Ferrets.
    J Virol. 2022 Mar 7:e0010022. doi: 10.1128/jvi.00100.
    PubMed     Abstract available


    February 2022
  33. JUNG C, Kmiec D, Koepke L, Zech F, et al
    Omicron: what makes the latest SARS-CoV-2 variant of concern so concerning?
    J Virol. 2022 Feb 28:jvi0207721. doi: 10.1128/jvi.02077.
    PubMed     Abstract available


  34. KIM EH, Nguyen TQ, Casel MAB, Rollon R, et al
    Coinfection of SARS-CoV-2 and Influenza A virus increased disease severity, impaired neutralizing antibody, and CD4+ T cell responses.
    J Virol. 2022 Feb 2:jvi0187321. doi: 10.1128/jvi.01873.
    PubMed     Abstract available


  35. ROSU ME, Kok A, Bestebroer TM, de Meulder D, et al
    Contribution of neuraminidase to the efficacy of seasonal split influenza vaccines in the ferret model.
    J Virol. 2022 Feb 2:jvi0195921. doi: 10.1128/jvi.01959.
    PubMed     Abstract available


  36. ARIUMI Y
    Host cellular RNA helicases regulate SARS-CoV-2 infection.
    J Virol. 2022 Feb 2:jvi0000222. doi: 10.1128/jvi.00002.
    PubMed     Abstract available


    January 2022
  37. MURER L, Petkidis A, Vallet T, Vignuzzi M, et al
    Chemical Evolution of Rhinovirus Identifies Capsid-Destabilizing Mutations Driving Low-pH-Independent Genome Uncoating.
    J Virol. 2022;96:e0106021.
    PubMed     Abstract available


  38. LIU S, Chou CK, Wu WW, Luan B, et al
    Stable Cell Clones Harboring Self-Replicating SARS-CoV-2 RNAs for Drug Screen.
    J Virol. 2022 Jan 26:jvi0221621. doi: 10.1128/jvi.02216.
    PubMed     Abstract available


  39. WONG TY, Horspool AM, Russ BP, Ye C, et al
    Evaluating antibody mediated protection against Alpha, Beta, and Delta SARS-CoV-2 variants of concern in K18-hACE2 transgenic mice.
    J Virol. 2022 Jan 26:jvi0218421. doi: 10.1128/jvi.02184.
    PubMed     Abstract available


  40. SPRUIT CM, Zhu X, Tomris I, Carrasco MR, et al
    N-glycolylneuraminic acid binding of avian and equine H7 influenza A viruses.
    J Virol. 2022 Jan 19:jvi0212021. doi: 10.1128/jvi.02120.
    PubMed     Abstract available


  41. BANERJEE S, De A, Kedia N, Bhakta K, et al
    The species-specific 282 residue in the PB2 subunit of the polymerase regulates RNA synthesis and replication of influenza A viruses infecting bat and non-bat hosts.
    J Virol. 2022 Jan 19:jvi0219021. doi: 10.1128/jvi.02190.
    PubMed     Abstract available


  42. MIYAMOTO S, Muramoto Y, Shindo K, Fujita-Fujiharu Y, et al
    Contribution of RNA-RNA interactions mediated by the genome packaging signals for the selective genome packaging of influenza A virus.
    J Virol. 2022 Jan 19:JVI0164121. doi: 10.1128/JVI.01641.
    PubMed     Abstract available


  43. DU S, Xu W, Wang Y, Li L, et al
    The "LLQY" motif on SARS-CoV-2 spike protein affects S incorporation into virus particles.
    J Virol. 2022 Jan 19:jvi0189721. doi: 10.1128/jvi.01897.
    PubMed     Abstract available


  44. TANG B, Sun EZ, Zhang ZL, Liu SL, et al
    Sphingomyelin-Sequestered Cholesterol Domain Recruits Formin-Binding Protein 17 for Constricting Clathrin-Coated Pits in Influenza Virus Entry.
    J Virol. 2022 Jan 12:JVI0181321. doi: 10.1128/JVI.01813.
    PubMed     Abstract available


  45. BHAT S, James J, Sadeyen JR, Mahmood S, et al
    Co-infection of chickens with H9N2 and H7N9 avian influenza viruses leads to emergence of reassortant H9N9 virus with increased fitness for poultry and a zoonotic potential.
    J Virol. 2022 Jan 12:jvi0185621. doi: 10.1128/jvi.01856.
    PubMed     Abstract available


  46. VELER H, Fan H, Keown J, Sharps J, et al
    The C-terminal domains of the PB2 subunit of the influenza A virus RNA polymerase directly interact with cellular GTPase Rab11a.
    J Virol. 2022 Jan 12:jvi0197921. doi: 10.1128/jvi.01979.
    PubMed     Abstract available


  47. RASHID MU, Gao A, Coombs KM
    Influenza A virus uses PSMA2 for downregulation of NRF2-mediated oxidative stress response.
    J Virol. 2022 Jan 12:jvi0199021. doi: 10.1128/jvi.01990.
    PubMed     Abstract available



  48. Articles of Significant Interest in This Issue.
    J Virol. 2022;96:e0186421.
    PubMed    


  49. CHAUDHRY MZ, Eschke K, Hoffmann M, Grashoff M, et al
    Rapid SARS-CoV-2 Adaptation to Available Cellular Proteases.
    J Virol. 2022 Jan 12:jvi0218621. doi: 10.1128/jvi.02186.
    PubMed     Abstract available


  50. KIMBLE JB, Wymore Brand M, Kaplan BS, Gauger P, et al
    Vaccine-associated enhanced respiratory disease following influenza virus infection in ferrets recapitulates the model in pigs.
    J Virol. 2022 Jan 5:JVI0172521. doi: 10.1128/JVI.01725.
    PubMed     Abstract available


    December 2021
  51. HUANG Y, Skarlupka AL, Jang H, Blas-Machado U, et al
    SARS-CoV-2 and Influenza A virus Co-infections in Ferrets.
    J Virol. 2021 Dec 22:JVI0179121. doi: 10.1128/JVI.01791.
    PubMed     Abstract available


  52. NILSSON-PAYANT BE, tenOever BR, Te Velthuis AJW
    The host factor ANP32A is required for influenza A virus vRNA and cRNA synthesis.
    J Virol. 2021 Dec 22:jvi0209221. doi: 10.1128/jvi.02092.
    PubMed     Abstract available


  53. OLIVARRIA GM, Cheng Y, Furman S, Pachow C, et al
    Microglia do not restrict SARS-CoV-2 replication following infection of the central nervous system of K18-hACE2 transgenic mice.
    J Virol. 2021 Dec 22:jvi0196921. doi: 10.1128/jvi.01969.
    PubMed     Abstract available


  54. ETTICH J, Werner J, Weitz HT, Mueller E, et al
    A hybrid soluble gp130/spike-nanobody fusion protein simultaneously blocks IL-6 trans-signaling and cellular infection with SARS-CoV2.
    J Virol. 2021 Dec 22:JVI0162221. doi: 10.1128/JVI.01622.
    PubMed     Abstract available


  55. GUO J, Chen J, Li Y, Li Y, et al
    SUMOylation of matrix protein M1 and filamentous morphology collectively contribute to the replication and virulence of highly pathogenic H5N1 avian influenza viruses in mammals.
    J Virol. 2021 Dec 15:JVI0163021. doi: 10.1128/JVI.01630.
    PubMed     Abstract available


  56. CAO K, Wang X, Peng H, Ding L, et al
    A Single Vaccine Protects against SARS-CoV-2 and Influenza Virus in Mice.
    J Virol. 2021 Dec 15:JVI0157821. doi: 10.1128/JVI.01578.
    PubMed     Abstract available


  57. NELSON M, O'Brien LM, Davies C, Keyser E, et al
    Comparison of experimental MERS-CoV infection acquired by three individual routes of infection in the common marmoset.
    J Virol. 2021 Dec 15:JVI0173921. doi: 10.1128/JVI.01739.
    PubMed     Abstract available


  58. SAKA N, Matsumoto Y, Ohta K, Kolakofsky D, et al
    A point mutation in human parainfluenza virus type 2 nucleoprotein leads to two separate effects on virus replication.
    J Virol. 2021 Dec 8:JVI0206721. doi: 10.1128/JVI.02067.
    PubMed     Abstract available


  59. ZHANG Y, Yan Q, Luo K, He P, et al
    Analysis of B cell receptor repertoires reveals key signatures of systemic B cell response after SARS-CoV-2 infection.
    J Virol. 2021 Dec 8:JVI0160021. doi: 10.1128/JVI.01600.
    PubMed     Abstract available


  60. MALICOAT J, Manivasagam S, Zuniga S, Sola I, et al
    Development of a Single-cycle Infectious SARS-CoV-2 Virus Replicon Particle System for use in BSL2 Laboratories.
    J Virol. 2021 Dec 1:JVI0183721. doi: 10.1128/JVI.01837.
    PubMed     Abstract available


    November 2021
  61. ZHANG S, Go EP, Ding H, Anang S, et al
    Glycosylation and disulfide bonding of wild-type SARS-CoV-2 spike glycoprotein.
    J Virol. 2021 Nov 24:JVI0162621. doi: 10.1128/JVI.01626.
    PubMed     Abstract available


  62. MARTINS M, Fernandes MHV, Joshi LR, Diel DG, et al
    Age-related susceptibility of ferrets to SARS-CoV-2 infection.
    J Virol. 2021 Nov 24:JVI0145521. doi: 10.1128/JVI.01455.
    PubMed     Abstract available


  63. BURCKHARDT RM, Dennehy JJ, Poon LLM, Saif LJ, et al
    Are COVID-19 Vaccine Boosters Needed? The Science behind Boosters.
    J Virol. 2021 Nov 24:JVI0197321. doi: 10.1128/JVI.01973.
    PubMed     Abstract available


  64. TAKAMATSU Y, Imai M, Maeda K, Nakajima N, et al
    Highly Neutralizing COVID-19 Convalescent Plasmas Potently Block SARS-CoV-2 Replication and Pneumonia in Syrian Hamsters.
    J Virol. 2021 Nov 24:JVI0155121. doi: 10.1128/JVI.01551.
    PubMed     Abstract available


  65. ZHANG H, Zheng H, Guo P, Hu L, et al
    Correction for Zhang et al., "Broadly Protective CD8(+) T Cell Immunity to Highly Conserved Epitopes Elicited by Heat Shock Protein gp96-Adjuvanted Influenza Monovalent Split Vaccine".
    J Virol. 2021;95:e0175021.
    PubMed    


  66. LIU Y, Wang B, Liang QZ, Shi FS, et al
    Roles of Two Major Domains of the Porcine Deltacoronavirus S1 Subunit in Receptor Binding and Neutralization.
    J Virol. 2021;95:e0111821.
    PubMed     Abstract available


  67. DANIELS RS, Galiano M, Ermetal B, Kwong J, et al
    Temporal and gene reassortment analysis of influenza C outbreaks in Hong Kong SAR, China.
    J Virol. 2021 Nov 17:JVI0192821. doi: 10.1128/JVI.01928.
    PubMed     Abstract available


  68. CHAI H, Li X, Li M, Lv X, et al
    Emergence, Evolution, and Pathogenicity of Influenza A(H7N4) Virus in Shorebirds, China.
    J Virol. 2021 Nov 17:JVI0171721. doi: 10.1128/JVI.01717.
    PubMed     Abstract available


  69. SOUZA CK, Anderson TK, Chang J, Venkatesh D, et al
    Antigenic distance between North American swine and human seasonal H3N2 influenza A viruses as an indication of zoonotic risk to humans.
    J Virol. 2021 Nov 10:JVI0137421. doi: 10.1128/JVI.01374.
    PubMed     Abstract available


  70. BASU A, Penumutchu S, Nguyen K, Mbonye U, et al
    A structurally conserved RNA element within SARS-CoV-2 ORF1a RNA and S mRNA regulates translation in response to viral S protein-induced signaling in human lung cells.
    J Virol. 2021 Nov 10:JVI0167821. doi: 10.1128/JVI.01678.
    PubMed     Abstract available


  71. DONG X, Wang X, Xie M, Wu W, et al
    Structural Basis of Human Parainfluenza Virus 3 Unassembled Nucleoprotein in Complex with Its Viral ChaperoneHPIV3 Nucleoprotein-Phosphoprotein Structure.
    J Virol. 2021 Nov 3:JVI0164821. doi: 10.1128/JVI.01648.
    PubMed     Abstract available


  72. LAMARCA AP, de Almeida LGP, da Silva Francisco Junior R, Cavalcante L, et al
    Genomic Surveillance Tracks the First Community Outbreak of the SARS-CoV-2 Delta (B.1.617.2) Variant in Brazil.
    J Virol. 2021 Nov 3:JVI0122821. doi: 10.1128/JVI.01228.
    PubMed     Abstract available


    October 2021
  73. DESCAMPS D, Peres de Oliveira A, Gonnin L, Madrieres S, et al
    Depletion of TAX1BP1 Amplifies Innate Immune Responses during Respiratory Syncytial Virus Infection.
    J Virol. 2021;95:e0091221.
    PubMed     Abstract available


  74. YAN B, Chakravorty S, Mirabelli C, Wang L, et al
    Reply to Grigoriev et al., "Sequences of SARS-CoV-2 "Hybrids" with the Human Genome: Signs 1 of Non-coding RNA?"
    J Virol. 2021 Oct 27:JVI0169021. doi: 10.1128/JVI.01690.
    PubMed     Abstract available


  75. YU J, Collins ND, Mercado NB, McMahan K, et al
    Protective Efficacy of Gastrointestinal SARS-CoV-2 Delivery Against Intranasal and Intratracheal SARS-CoV-2 Challenge in Rhesus Macaques.
    J Virol. 2021 Oct 27:JVI0159921. doi: 10.1128/JVI.01599.
    PubMed     Abstract available


  76. GRIGORIEV A, Kelley JJ, Guan L
    Sequences of SARS-CoV-2 "Hybrids" with the Human Genome: Signs of Non-coding RNA?
    J Virol. 2021 Oct 27:JVI0146221. doi: 10.1128/JVI.01462.
    PubMed     Abstract available


  77. TAN J, O'Dell G, Hernandez MM, Sordillo EM, et al
    Human anti-neuraminidase antibodies reduce airborne transmission of clinical influenza virus isolates in the guinea pig model.
    J Virol. 2021 Oct 20:JVI0142121. doi: 10.1128/JVI.01421.
    PubMed     Abstract available


  78. WINKLER ES, Chen RE, Alam F, Yildiz S, et al
    SARS-CoV-2 causes lung infection without severe disease in human ACE2 knock-in mice.
    J Virol. 2021 Oct 20:JVI0151121. doi: 10.1128/JVI.01511.
    PubMed     Abstract available


  79. DONG W, Mead H, Tian L, Park JG, et al
    The K18-hACE2 Transgenic Mouse Model Recapitulates Non-Severe and Severe COVID-19 in Response to Infectious Dose of SARS-CoV-2 Virus.
    J Virol. 2021 Oct 20:JVI0096421. doi: 10.1128/JVI.00964.
    PubMed     Abstract available


  80. REN W, Zhu Y, Lan J, Chen H, et al
    Susceptibilities of human ACE2 genetic variants in coronavirus infection.
    J Virol. 2021 Oct 20:JVI0149221. doi: 10.1128/JVI.01492.
    PubMed     Abstract available


  81. SIDDIQ MM, Chan AT, Miorin L, Yadaw AS, et al
    Functional Effects of Cardiomyocyte Injury in COVID-19.
    J Virol. 2021 Oct 20:JVI0106321. doi: 10.1128/JVI.01063.
    PubMed     Abstract available


  82. GAO Q, Yang C, Ren C, Zhang S, et al
    Correction for Gao et al., "Eukaryotic Translation Elongation Factor 1 Delta Inhibits the Nuclear Import of the Nucleoprotein and PA-PB1 Heterodimer of Influenza A Virus".
    J Virol. 2021;95:e0141321.
    PubMed    


  83. GAO J, Klenow L, Parsons L, Malik T, et al
    Design of the Recombinant Influenza Neuraminidase Antigen is Crucial for its Biochemical Properties and Protective Efficacy.
    J Virol. 2021 Oct 6:JVI0116021. doi: 10.1128/JVI.01160.
    PubMed     Abstract available


  84. BESSIERE P, Figueroa T, Coggon A, Foret-Lucas C, et al
    Opposite outcomes of the within-host competition between highly and low pathogenic H5N8 avian influenza viruses in chickens compared to ducks.
    J Virol. 2021 Oct 6:JVI0136621. doi: 10.1128/JVI.01366.
    PubMed     Abstract available


  85. NAVARATNARAJAH CK, Pease DR, Halfmann P, Taye B, et al
    Highly efficient SARS-CoV-2 infection of human cardiomyocytes: spike protein-mediated cell fusion and its inhibition.
    J Virol. 2021 Oct 6:JVI0136821. doi: 10.1128/JVI.01368.
    PubMed     Abstract available


    September 2021
  86. SIEGERS JY, Dhanasekaran V, Xie R, Deng YM, et al
    Genetic and Antigenic Characterization of an Influenza A(H3N2) Outbreak in Cambodia and the Greater Mekong Subregion during the COVID-19 Pandemic, 2020.
    J Virol. 2021 Sep 29:JVI0126721. doi: 10.1128/JVI.01267.
    PubMed     Abstract available


  87. SHUE B, Chiramel AI, Cerikan B, To TH, et al
    Genome-wide CRISPR screen identifies RACK1 as a critical host factor for flavivirus replication.
    J Virol. 2021 Sep 29:JVI0059621. doi: 10.1128/JVI.00596.
    PubMed     Abstract available


  88. KIM YJ, Witwit H, Cubitt B, de la Torre JC, et al
    Inhibitors of anti-apoptotic Bcl-2 family proteins exhibit potent and broad-spectrum anti-mammarenavirus activity via cell cycle arrest at G0/G1 phase.
    J Virol. 2021 Sep 29:JVI0139921. doi: 10.1128/JVI.01399.
    PubMed     Abstract available


  89. PELZ L, Rudiger D, Dogra T, Alnaji FG, et al
    Semi-continuous propagation of influenza A virus and its defective interfering particles: analyzing the dynamic competition to select candidates for antiviral therapy.
    J Virol. 2021 Sep 22:JVI0117421. doi: 10.1128/JVI.01174.
    PubMed     Abstract available


  90. QIAN Y, Lei T, Patel PS, Lee CH, et al
    Direct activation of endothelial cells by SARS-CoV-2 nucleocapsid protein is blocked by Simvastatin.
    J Virol. 2021 Sep 22:JVI0139621. doi: 10.1128/JVI.01396.
    PubMed     Abstract available


  91. CHOI A, Koch M, Wu K, Dixon G, et al
    Serum Neutralizing Activity of mRNA-1273 Against SARS-CoV-2 Variants.
    J Virol. 2021 Sep 22:JVI0131321. doi: 10.1128/JVI.01313.
    PubMed     Abstract available


  92. ACHARYA A, Pandey K, Thurman M, Klug E, et al
    Discovery and evaluation of entry inhibitors for SARS-CoV-2 and its emerging variants.
    J Virol. 2021 Sep 22:JVI0143721. doi: 10.1128/JVI.01437.
    PubMed     Abstract available


  93. SHANG C, Zhuang X, Zhang H, Li Y, et al
    Inhibition of autophagy suppresses SARS-CoV-2 replication and ameliorates pneumonia in hACE2 transgenic mice and xenografted human lung tissues.
    J Virol. 2021 Sep 22:JVI0153721. doi: 10.1128/JVI.01537.
    PubMed     Abstract available


  94. KIRCHENBAUM GA, Sautto GA, Richardson RA, Ecker JW, et al
    A competitive hemagglutination inhibition assay for dissecting functional antibody activity to influenza virus.
    J Virol. 2021 Sep 15:JVI0237920. doi: 10.1128/JVI.02379.
    PubMed     Abstract available


  95. TOSTANOSKI LH, Gralinski LE, Martinez DR, Schaefer A, et al
    Protective efficacy of rhesus adenovirus COVID-19 vaccines against mouse-adapted SARS-CoV-2.
    J Virol. 2021 Sep 15:JVI0097421. doi: 10.1128/JVI.00974.
    PubMed     Abstract available


  96. NILSSON-PAYANT BE, Uhl S, Grimont A, Doane AS, et al
    The NF-kappaB transcriptional footprint is essential for SARS-CoV-2 replication.
    J Virol. 2021 Sep 15:JVI0125721. doi: 10.1128/JVI.01257.
    PubMed     Abstract available


  97. CHIEM K, Morales Vasquez D, Silvas JA, Park JG, et al
    A bifluorescent-based assay for the identification of neutralizing antibodies against SARS-CoV-2 variants of concern in vitro and in vivo.
    J Virol. 2021 Sep 8:JVI0112621. doi: 10.1128/JVI.01126.
    PubMed     Abstract available


  98. ABRAHAM M, Beavis AC, Xiao P, Villinger FJ, et al
    Evaluation of a new viral vaccine vector in mice and rhesus macaques: J paramyxovirus (JPV)-expressing HA of influenza A virus H5N1.
    J Virol. 2021 Sep 1:JVI0132121. doi: 10.1128/JVI.01321.
    PubMed     Abstract available


  99. WILLIAMS CM, Roy S, Califano D, McKenzie ANJ, et al
    IL-33-ILC2 axis represents a potential adjuvant target to increase the cross-protective efficacy of influenza vaccine.
    J Virol. 2021 Sep 1:JVI0059821. doi: 10.1128/JVI.00598.
    PubMed     Abstract available


    August 2021
  100. XUN G, Song X, Hu J, Zhang H, et al
    Potent Human Single-Domain Antibodies Specific for a Novel Prefusion Epitope of Respiratory Syncytial Virus F Glycoprotein.
    J Virol. 2021;95:e0048521.
    PubMed     Abstract available


  101. SATO K, Hayashi H, Shimotai Y, Yamaya M, et al
    TMPRSS2 activates hemagglutinin-esterase glycoprotein of influenza C virus.
    J Virol. 2021 Aug 18:JVI0129621. doi: 10.1128/JVI.01296.
    PubMed     Abstract available


  102. KREUTZBERGER AJB, Sanyal A, Ojha R, Pyle JD, et al
    Synergistic block of SARS-CoV-2 infection by combined drug inhibition of the host entry factors PIKfyve kinase and TMPRSS2 protease.
    J Virol. 2021 Aug 18:JVI0097521. doi: 10.1128/JVI.00975.
    PubMed     Abstract available


  103. KAPLAN BS, Anderson TK, Chang J, Santos J, et al
    Evolution and antigenic advancement of N2 neuraminidase of swine influenza A viruses circulating in the United States following two separate introductions from human seasonal viruses.
    J Virol. 2021 Aug 11:JVI0063221. doi: 10.1128/JVI.00632.
    PubMed     Abstract available


  104. KAWAI A, Yamamoto Y, Nogimori T, Takeshita K, et al
    The potential of neuraminidase as an antigen for nasal vaccines to increase cross-protection against influenza viruses.
    J Virol. 2021 Aug 11:JVI0118021. doi: 10.1128/JVI.01180.
    PubMed     Abstract available


  105. TAM EH, Liu YC, Woung CH, Liu HM, et al
    Role of the chaperone protein 14-3-3epsilon in the regulation of influenza A virus-activated beta interferon.
    J Virol. 2021 Aug 11:JVI0023121. doi: 10.1128/JVI.00231.
    PubMed     Abstract available


  106. LU M, Zhang Y, Dravid P, Li A, et al
    A methyltransferase-defective VSV-based SARS-CoV-2 vaccine candidate provides complete protection against SARS-CoV-2 infection in hamsters.
    J Virol. 2021 Aug 11:JVI0059221. doi: 10.1128/JVI.00592.
    PubMed     Abstract available


    July 2021
  107. DEL SARTO J, Gerlt V, Friedrich ME, Anhlan D, et al
    Phosphorylation of JIP4 at S730 presents anti-viral properties against influenza A virus infection.
    J Virol. 2021 Jul 28:JVI0067221. doi: 10.1128/JVI.00672.
    PubMed     Abstract available


  108. BESTLE D, Limburg H, Kruhl D, Harbig A, et al
    Hemagglutinins of avian influenza viruses are proteolytically activated by TMPRSS2 in human and murine airway cells.
    J Virol. 2021 Jul 28:JVI0090621. doi: 10.1128/JVI.00906.
    PubMed     Abstract available


  109. CANTWELL AM, Singh H, Platt M, Yu Y, et al
    Kinetic multi-omic analysis of responses to SARS-CoV-2 infection in a model of severe COVID-19.
    J Virol. 2021 Jul 28:JVI0101021. doi: 10.1128/JVI.01010.
    PubMed     Abstract available


  110. RAHMAN K, Compton AA
    The indirect antiviral potential of long non-coding RNAs encoded by IFITM pseudogenes.
    J Virol. 2021 Jul 28:JVI0068021. doi: 10.1128/JVI.00680.
    PubMed     Abstract available


  111. GREEN G, Johnson SM, Costello H, Brakel K, et al
    CX3CR1 Is a Receptor for Human Respiratory Syncytial Virus in Cotton Rats.
    J Virol. 2021;95:e0001021.
    PubMed     Abstract available


  112. YANG J, Zhang P, Huang M, Qiao S, et al
    Key amino acids of M1-41 and M2-27 determine growth and pathogenicity of chimeric H17 bat influenza virus in cells and in mice.
    J Virol. 2021 Jul 21:JVI0101921. doi: 10.1128/JVI.01019.
    PubMed     Abstract available


  113. LI Z, Gao F, Lan Y, Guan J, et al
    Porcine Haemagglutinating Encephalomyelitis Virus Triggers Neural Autophagy Independent of ULK1.
    J Virol. 2021 Jul 21:JVI0085121. doi: 10.1128/JVI.00851.
    PubMed     Abstract available


  114. FERRARI M, Mekkaoui L, Ilca FT, Akbar Z, et al
    Characterisation of a novel ACE2-based therapeutic with enhanced rather than reduced activity against SARS-CoV-2 variants.
    J Virol. 2021 Jul 21:JVI0068521. doi: 10.1128/JVI.00685.
    PubMed     Abstract available


  115. CHEN DY, Khan N, Close BJ, Goel RK, et al
    SARS-CoV-2 disrupts proximal elements in the JAK-STAT pathway.
    J Virol. 2021 Jul 14:JVI0086221. doi: 10.1128/JVI.00862.
    PubMed     Abstract available


  116. LAI KK, Cheung NN, Yang F, Dai J, et al
    Correction for Lai et al., "Identification of Novel Fusion Inhibitors of Influenza A Virus by Chemical Genetics".
    J Virol. 2021;95:e0066521.
    PubMed    


  117. LIANG W, Zhang Y, Li M, Al-Shaebi F, et al
    Cyclophilin A Inhibits Human Respiratory Syncytial Virus (RSV) Replication by Binding to RSV-N through Its PPIase Activity.
    J Virol. 2021;95:e0056321.
    PubMed     Abstract available


  118. LEYSON CM, Youk S, Ferreira HL, Suarez DL, et al
    Multiple gene segments are associated with enhanced virulence of clade 2.3.4.4 H5N8 highly pathogenic avian influenza virus in mallards.
    J Virol. 2021 Jul 7:JVI0095521. doi: 10.1128/JVI.00955.
    PubMed     Abstract available


    June 2021
  119. YU J, Huang C, Sheng Z, Wang Z, et al
    Identification of One Critical Amino Acid Residue of the Nucleoprotein as a Determinant for in vitro Viral Replication Fitness of Influenza D Virus.
    J Virol. 2021 Jun 30:JVI0097121. doi: 10.1128/JVI.00971.
    PubMed     Abstract available


  120. XIAO Y, Zhang W, Pan M, Bauer DLV, et al
    A synergistic effect between 3' terminal noncoding and adjacent coding regions of influenza A virus HA segment on template preference.
    J Virol. 2021 Jun 30:JVI0087821. doi: 10.1128/JVI.00878.
    PubMed     Abstract available


  121. NGUYEN HT, Falzarano D, Gerdts V, Liu Q, et al
    Construction of a non-infectious SARS-CoV-2 replicon for antiviral drug testing and gene function studies.
    J Virol. 2021 Jun 30:JVI0068721. doi: 10.1128/JVI.00687.
    PubMed     Abstract available


  122. BLAUROCK C, Breithaupt A, Scheibner D, Bagato O, et al
    Preferential selection and contribution of non-structural protein 1 (NS1) to the efficient transmission of the panzootic avian influenza H5N8 2.3.4.4 clades A and B viruses in chickens and ducks.
    J Virol. 2021 Jun 23:JVI0044521. doi: 10.1128/JVI.00445.
    PubMed     Abstract available


  123. SKARLUPKA AL, Bebin-Blackwell AG, Sumner SF, Ross TM, et al
    Universal influenza virus neuraminidase vaccine elicits protective immune responses against human seasonal and pre-pandemic strains.
    J Virol. 2021 Jun 23:JVI0075921. doi: 10.1128/JVI.00759.
    PubMed     Abstract available


  124. SUN G, Sui Y, Zhou Y, Ya J, et al
    Structural basis of covalent inhibitory mechanism of TMPRSS2-related serine proteases by camostat.
    J Virol. 2021 Jun 23:JVI0086121. doi: 10.1128/JVI.00861.
    PubMed     Abstract available


  125. KUMAR A, Ishida R, Strilets T, Cole J, et al
    SARS-CoV-2 Nonstructural Protein 1 Inhibits the Interferon Response by Causing Depletion of Key Host Signaling Factors.
    J Virol. 2021;95:e0026621.
    PubMed     Abstract available


  126. WANG X, Zhao Y, Yan F, Wang T, et al
    Viral and host transcriptomes in SARS-CoV-2 infected human lung cells.
    J Virol. 2021 Jun 9:JVI0060021. doi: 10.1128/JVI.00600.
    PubMed     Abstract available


  127. NELSON SA, Dileepan T, Rasley A, Jenkins MK, et al
    Intranasal nanoparticle vaccination elicits a persistent, polyfunctional CD4 T cell response in the murine lung specific for a highly conserved influenza antigen that are sufficient to mediate protection from influenza virus challenge.
    J Virol. 2021 Jun 2:JVI0084121. doi: 10.1128/JVI.00841.
    PubMed     Abstract available


  128. OU J, Zhou Z, Dai R, Zhang J, et al
    V367F mutation in SARS-CoV-2 spike RBD emerging during the early transmission phase enhances viral infectivity through increased human ACE2 receptor binding affinity.
    J Virol. 2021 Jun 2:JVI0061721. doi: 10.1128/JVI.00617.
    PubMed     Abstract available


    May 2021
  129. LIU H, Plancarte M, Ball EE, Weiss CM, et al
    Respiratory tract explant infection dynamics of influenza A virus in California sea lions, northern elephant seals, and rhesus macaques.
    J Virol. 2021 May 26:JVI0040321. doi: 10.1128/JVI.00403.
    PubMed     Abstract available


  130. BAKRE A, Jones L, Murray J, Reneer ZB, et al
    Innate antiviral cytokine response to swine influenza virus by swine respiratory epithelial cells.
    J Virol. 2021 May 12. pii: JVI.00692-21. doi: 10.1128/JVI.00692.
    PubMed     Abstract available


  131. YAN B, Chakravorty S, Mirabelli C, Wang L, et al
    Host-virus chimeric events in SARS-CoV2 infected cells are infrequent and artifactual.
    J Virol. 2021 May 12. pii: JVI.00294-21. doi: 10.1128/JVI.00294.
    PubMed     Abstract available


  132. LULLA V, Wandel MP, Bandyra KJ, Ulferts R, et al
    Targeting the conserved stem loop 2 motif in the SARS-CoV-2 genome.
    J Virol. 2021 May 7. pii: JVI.00663-21. doi: 10.1128/JVI.00663.
    PubMed     Abstract available


  133. TRIBOLET L, Alexander MR, Brice AM, van Vuren PJ, et al
    ILRUN downregulates ACE2 expression and blocks infection of human cells by SARS-CoV-2.
    J Virol. 2021 May 7. pii: JVI.00327-21. doi: 10.1128/JVI.00327.
    PubMed     Abstract available


  134. LEE W, Kingstad-Bakke B, Kedl RM, Kawaoka Y, et al
    CCR2 Regulates Vaccine-Induced Mucosal T-Cell Memory to Influenza A Virus.
    J Virol. 2021 May 5. pii: JVI.00530-21. doi: 10.1128/JVI.00530.
    PubMed     Abstract available


  135. HORMAN WSJ, Kedzierska K, Rootes CL, Bean AGD, et al
    Upregulated expression of ferret Interferon-Inducible Transmembrane genes by IFN-alpha and influenza virus infection.
    J Virol. 2021 May 5. pii: JVI.00111-21. doi: 10.1128/JVI.00111.
    PubMed     Abstract available


    April 2021
  136. RESNICK SJ, Iketani S, Hong SJ, Zask A, et al
    Inhibitors of coronavirus 3CL proteases protect cells from protease-mediated cytotoxicity.
    J Virol. 2021 Apr 28. pii: JVI.02374-20. doi: 10.1128/JVI.02374.
    PubMed     Abstract available


  137. ALFI O, Yakirevitch A, Wald O, Wandel O, et al
    Human nasal and lung tissues infected ex vivo with SARS-CoV-2 provide insights into differential tissue-specific and virus-specific innate immune responses in the upper and lower respiratory tract.
    J Virol. 2021 Apr 23. pii: JVI.00130-21. doi: 10.1128/JVI.00130.
    PubMed     Abstract available


  138. VIDAL SJ, Collier AY, Yu J, McMahan K, et al
    Correlates of Neutralization Against SARS-CoV-2 Variants of Concern by Early Pandemic Sera.
    J Virol. 2021 Apr 23. pii: JVI.00404-21. doi: 10.1128/JVI.00404.
    PubMed     Abstract available


  139. SAUTTO GA, Ecker JW, Ross TM
    An H1N1 Computationally Optimized Broadly Reactive Antigen elicits a neutralizing antibody response against an emerging human-infecting Eurasian avian-like swine influenza virus.
    J Virol. 2021 Apr 14. pii: JVI.02421-20. doi: 10.1128/JVI.02421.
    PubMed     Abstract available


  140. CHIEM K, Lopez-Garcia D, Ortego J, Martinez-Sobrido L, et al
    Identification of amino acid residues required for inhibition of host gene expression by influenza A/Viet Nam/1203/2004 H5N1 PA-X.
    J Virol. 2021 Apr 14. pii: JVI.00408-21. doi: 10.1128/JVI.00408.
    PubMed     Abstract available


  141. NILSSON-PAYANT BE, Blanco-Melo D, Uhl S, Escudero-Perez B, et al
    Reduced Nucleoprotein Availability Impairs Negative-Sense RNA Virus Replication and Promotes Host Recognition.
    J Virol. 2021;95.
    PubMed     Abstract available


  142. MORI K, Ohniwa RL, Takizawa N, Naito T, et al
    Development of a Genetically Stable Live Attenuated Influenza Vaccine Strain using an Engineered High-Fidelity Viral Polymerase.
    J Virol. 2021 Apr 7. pii: JVI.00493-21. doi: 10.1128/JVI.00493.
    PubMed     Abstract available


  143. ZHENG J, Wen L, Yen HL, Liu M, et al
    Phenotypic and functional characteristics of a novel influenza hemagglutinin-specific memory NK cell.
    J Virol. 2021 Apr 7. pii: JVI.00165-21. doi: 10.1128/JVI.00165.
    PubMed     Abstract available


  144. ZHANG H, Zheng H, Guo P, Hu L, et al
    Broadly protective CD8(+) T cell immunity to highly conserved epitopes elicited by heat shock protein gp96-adjuvanted influenza monovalent split vaccine.
    J Virol. 2021 Apr 7. pii: JVI.00507-21. doi: 10.1128/JVI.00507.
    PubMed     Abstract available


  145. PATEL DR, Field CJ, Septer KM, Sim DG, et al
    Transmission and protection against re-infection in the ferret model with the SARS-CoV-2 USA-WA1/2020 reference isolate.
    J Virol. 2021 Apr 7. pii: JVI.02232-20. doi: 10.1128/JVI.02232.
    PubMed     Abstract available


    March 2021
  146. WANG J, Shu T, Deng W, Zheng Y, et al
    Mucosal priming with a recombinant influenza A virus-vectored vaccine elicits T-cell and antibody responses to HIV-1 in mice.
    J Virol. 2021 Mar 31. pii: JVI.00059-21. doi: 10.1128/JVI.00059.
    PubMed     Abstract available


  147. LIU W, Reyes HM, Yang JF, Li Y, et al
    Activation of STING signaling pathway effectively blocks human coronavirus infection.
    J Virol. 2021 Mar 31. pii: JVI.00490-21. doi: 10.1128/JVI.00490.
    PubMed     Abstract available


  148. TOMITA Y, Matsuyama S, Fukuhara H, Maenaka K, et al
    The physiological TMPRSS2 inhibitor HAI-2 alleviates SARS-CoV-2 infection.
    J Virol. 2021 Mar 31. pii: JVI.00434-21. doi: 10.1128/JVI.00434.
    PubMed     Abstract available


  149. SLAINE PD, Kleer M, Duguay BA, Pringle ES, et al
    Thiopurines activate an antiviral unfolded protein response that blocks influenza A virus glycoprotein accumulation.
    J Virol. 2021 Mar 24. pii: JVI.00453-21. doi: 10.1128/JVI.00453.
    PubMed     Abstract available


  150. DANZY S, Lowen AC, Steel J
    A quantitative approach to assess influenza A virus fitness and transmission in guinea pigs.
    J Virol. 2021 Mar 17. pii: JVI.02320-20. doi: 10.1128/JVI.02320.
    PubMed     Abstract available


  151. PU J, Yin Y, Liu J, Wang X, et al
    Reassortment with dominant chicken H9N2 influenza virus contributed to the fifth H7N9 virus human epidemic.
    J Virol. 2021 Mar 17. pii: JVI.01578-20. doi: 10.1128/JVI.01578.
    PubMed     Abstract available


  152. YANG H, Winkler W, Wu X
    Interferon Inducer IFI35 regulates RIG-I-mediated innate antiviral response through mutual antagonism with Influenza protein NS1.
    J Virol. 2021 Mar 10. pii: JVI.00283-21. doi: 10.1128/JVI.00283.
    PubMed     Abstract available


  153. PENG J, Ran Y, Xie H, Deng L, et al
    Sarco/Endoplasmic Reticulum Ca(2+) Transporting ATPase (SERCA) Modulates Autophagic, Inflammatory, and Mitochondrial Responses during Influenza A Virus Infection in Human Lung Cells.
    J Virol. 2021 Mar 10. pii: JVI.00217-21. doi: 10.1128/JVI.00217.
    PubMed     Abstract available


  154. GONG W, He X, Huang K, Zhang Y, et al
    Interaction of NEP with G Protein Pathway Suppressor 2 Facilitates Influenza A Virus Replication by Weakening the Inhibition of GPS2 to RNA Synthesis and Ribonucleoprotein Assembly.
    J Virol. 2021 Mar 3. pii: JVI.00008-21. doi: 10.1128/JVI.00008.
    PubMed     Abstract available


  155. PHAN T, Fay EJ, Lee Z, Aron S, et al
    Segment-specific kinetics of mRNA, cRNA and vRNA accumulation during influenza infection.
    J Virol. 2021 Mar 3. pii: JVI.02102-20. doi: 10.1128/JVI.02102.
    PubMed     Abstract available


  156. LUO Z, Girton AW, Heaton BE, Heaton NS, et al
    Engineered influenza virions reveal the contributions of non-hemagglutinin structural proteins to vaccine mediated protection.
    J Virol. 2021 Mar 3. pii: JVI.02021-20. doi: 10.1128/JVI.02021.
    PubMed     Abstract available


    February 2021
  157. JEONG JH, Choi WS, Antigua KJC, Choi YK, et al
    Correction for Jeong et al., "In Vitro Profiling of Laninamivir-Resistant Substitutions in N3 to N9 Avian Influenza Virus Neuraminidase Subtypes and Their Association with In Vivo Susceptibility".
    J Virol. 2021;95.
    PubMed    


  158. YANG F, Pang B, Lai KK, Cheung NN, et al
    Discovery of a novel specific inhibitor targeting influenza A nucleoprotein with pleiotropic inhibitory effects on various steps of viral life cycle.
    J Virol. 2021 Feb 24. pii: JVI.01432-20. doi: 10.1128/JVI.01432.
    PubMed     Abstract available


  159. DHAKAL S, Loube J, Misplon JA, Lo CY, et al
    Effect of an adenovirus-vectored universal influenza virus vaccine on pulmonary pathophysiology in a mouse model.
    J Virol. 2021 Feb 24. pii: JVI.02359-20. doi: 10.1128/JVI.02359.
    PubMed     Abstract available


  160. HOYE BJ, Donato CM, Lisovski S, Deng YM, et al
    Reassortment and persistence of influenza A viruses from diverse geographic origins within Australian wild birds: evidence from a small, isolated population of Ruddy turnstones.
    J Virol. 2021 Feb 24. pii: JVI.02193-20. doi: 10.1128/JVI.02193.
    PubMed     Abstract available


  161. BINJAWADAGI B, Ma Y, Binjawadagi R, Brakel K, et al
    Mucosal Delivery of Recombinant Vesicular Stomatitis Virus Vectors Expressing Envelope Proteins of Respiratory Syncytial Virus Induces Protective Immunity in Cotton Rats.
    J Virol. 2021;95.
    PubMed     Abstract available


  162. HORNICH BF, Grosskopf AK, Schlagowski S, Tenbusch M, et al
    SARS-CoV-2 and SARS-CoV spike-mediated cell-cell fusion differ in the requirements for receptor expression and proteolytic activation.
    J Virol. 2021 Feb 19. pii: JVI.00002-21. doi: 10.1128/JVI.00002.
    PubMed     Abstract available


  163. ORR-BURKS N, Murray J, Todd KV, Bakre A, et al
    GPCR and ion channel genes used by influenza virus for replication.
    J Virol. 2021 Feb 3. pii: JVI.02410-20. doi: 10.1128/JVI.02410.
    PubMed     Abstract available


    January 2021
  164. LEVENE RE, Shrestha SD, Gaglia MM
    The influenza A virus host shutoff factor PA-X is rapidly turned over in a strain-specific manner.
    J Virol. 2021 Jan 27. pii: JVI.02312-20. doi: 10.1128/JVI.02312.
    PubMed     Abstract available


  165. ZHANG X, Pu J, Sun Y, Yuhai B, et al
    Neurovirulence of avian influenza virus is dependent on the interaction of viral NP protein with host factor FMRP in the murine brain.
    J Virol. 2021 Jan 6. pii: JVI.01272-20. doi: 10.1128/JVI.01272.
    PubMed     Abstract available


  166. PATIL A, Anhlan D, Ferrando V, Mecate-Zambrano A, et al
    Phosphorylation of influenza A virus NS1 at serine 205 mediates its viral polymerase-enhancing function.
    J Virol. 2021 Jan 6. pii: JVI.02369-20. doi: 10.1128/JVI.02369.
    PubMed     Abstract available


  167. FENG M, Zhang Q, Wu W, Chen L, et al
    Inducible Guanylate-Binding Protein 7 Facilitates Influenza A Virus Replication by Suppressing Innate Immunity via NF-kappaB and JAK-STAT Signaling Pathways.
    J Virol. 2021 Jan 6. pii: JVI.02038-20. doi: 10.1128/JVI.02038.
    PubMed     Abstract available


  168. OHTA K, Saka N, Nishio M
    Human parainfluenza virus type 2 V protein modulates iron homeostasis.
    J Virol. 2021 Jan 6. pii: JVI.01861-20. doi: 10.1128/JVI.01861.
    PubMed     Abstract available


    December 2020
  169. WANG Q, Pan W, Wang S, Pan C, et al
    Protein tyrosine phosphatase SHP2 suppresses host innate immunity against influenza A virus through regulating EGFR-mediated signaling.
    J Virol. 2020 Dec 23. pii: JVI.02001-20. doi: 10.1128/JVI.02001.
    PubMed     Abstract available


  170. VERHAGEN JH, Eriksson P, Leijten L, Blixt O, et al
    Host range of influenza A virus H1 to H16 in Eurasian ducks based on tissue and receptor binding studies.
    J Virol. 2020 Dec 23. pii: JVI.01873-20. doi: 10.1128/JVI.01873.
    PubMed     Abstract available


  171. HUMAN S, Hotard AL, Rostad CA, Lee S, et al
    A Respiratory Syncytial Virus Attachment Gene Variant Associated with More Severe Disease in Infants Decreases Fusion Protein Expression, Which May Facilitate Immune Evasion.
    J Virol. 2020;95.
    PubMed     Abstract available


  172. LEE E, Sandgren K, Duette G, Stylianou VV, et al
    Identification of SARS-CoV-2 Nucleocapsid and Spike T-cell Epitopes for Assessing T-cell Immunity.
    J Virol. 2020 Dec 21. pii: JVI.02002-20. doi: 10.1128/JVI.02002.
    PubMed     Abstract available


  173. YOUK SS, Leyson CM, Seibert BA, Jadhao S, et al
    Mutations in PB1, NP, HA, and NA Contribute to Increased Virus Fitness of H5N2 Highly Pathogenic Avian Influenza Virus Clade 2.3.4.4 in Chickens.
    J Virol. 2020 Dec 2. pii: JVI.01675-20. doi: 10.1128/JVI.01675.
    PubMed     Abstract available


  174. BIMLER L, Ronzulli SL, Song AY, Johnson SK, et al
    Matrix Protein 2 Extracellular Domain-Specific Monoclonal Antibodies Are an Effective and Potentially Universal Treatment for Influenza A.
    J Virol. 2020 Dec 2. pii: JVI.01027-20. doi: 10.1128/JVI.01027.
    PubMed     Abstract available


  175. EVERETT HE, van Diemen PM, Aramouni M, Ramsay A, et al
    Vaccines That Reduce Viral Shedding Do Not Prevent Transmission of H1N1 Pandemic 2009 Swine Influenza a Virus Infection to Unvaccinated Pigs.
    J Virol. 2020 Dec 2. pii: JVI.01787-20. doi: 10.1128/JVI.01787.
    PubMed     Abstract available


  176. PEACOCK TP, Sealy JE, Harvey WT, Benton DJ, et al
    Genetic determinants of receptor-binding preference and zoonotic potential of H9N2 avian influenza viruses.
    J Virol. 2020 Dec 2. pii: JVI.01651-20. doi: 10.1128/JVI.01651.
    PubMed     Abstract available


    November 2020
  177. PAHMEIER F, Neufeldt CJ, Cerikan B, Prasad V, et al
    A Versatile Reporter System to Monitor Virus Infected Cells and Its Application to Dengue Virus and SARS-CoV-2.
    J Virol. 2020 Nov 30. pii: JVI.01715-20. doi: 10.1128/JVI.01715.
    PubMed     Abstract available


  178. CLARK LK, Green TJ, Petit CM
    Structure of nonstructural protein 1 from SARS-CoV-2.
    J Virol. 2020 Nov 24. pii: JVI.02019-20. doi: 10.1128/JVI.02019.
    PubMed     Abstract available


  179. MILEWSKA A, Chi Y, Szczepanski A, Barreto-Duran E, et al
    HTCC as a Polymeric Inhibitor of SARS-CoV-2 and MERS-CoV.
    J Virol. 2020 Nov 20. pii: JVI.01622-20. doi: 10.1128/JVI.01622.
    PubMed     Abstract available


  180. MA N, Li X, Jiang H, Dai Y, et al
    Influenza neuraminidase engages CD83 and promotes pulmonary injury.
    J Virol. 2020 Nov 11. pii: JVI.01753-20. doi: 10.1128/JVI.01753.
    PubMed     Abstract available


  181. BAO D, Xue R, Zhang M, Lu C, et al
    N-linked glycosylation plays an important role in budding of NA protein and virulence of influenza viruses.
    J Virol. 2020 Nov 11. pii: JVI.02042-20. doi: 10.1128/JVI.02042.
    PubMed     Abstract available


  182. TIAN X, Landreth S, Lu Y, Pandey K, et al
    A Replication-Defective Influenza Virus Harboring H5 and H7 Hemagglutinins Provides Protection against H5N1 and H7N9 Infection in Mice.
    J Virol. 2020 Nov 11. pii: JVI.02154-20. doi: 10.1128/JVI.02154.
    PubMed     Abstract available


  183. JENKINS T, Wang R, Harder O, Xue M, et al
    A novel live attenuated RSV vaccine candidate with mutations in the L protein SAM binding site and the G protein cleavage site is protective in cotton rats and a rhesus macaque.
    J Virol. 2020 Nov 11. pii: JVI.01568-20. doi: 10.1128/JVI.01568.
    PubMed     Abstract available


  184. FENWICK C, Croxatto A, Coste AT, Pojer F, et al
    Changes in SARS-CoV-2 Spike versus Nucleoprotein Antibody Responses Impact the Estimates of Infections in Population-Based Seroprevalence Studies.
    J Virol. 2020 Nov 3. pii: JVI.01828-20. doi: 10.1128/JVI.01828.
    PubMed     Abstract available


    October 2020
  185. DIEZ-FUERTES F, Iglesias-Caballero M, Garcia Perez J, Monzon S, et al
    A FOUNDER EFFECT LED EARLY SARS-COV-2 TRANSMISSION IN SPAIN.
    J Virol. 2020 Oct 30. pii: JVI.01583-20. doi: 10.1128/JVI.01583.
    PubMed     Abstract available


  186. LIANG B, Matsuoka Y, Le Nouen C, Liu X, et al
    A parainfluenza virus vector expressing the respiratory syncytial virus (RSV) prefusion F protein is more effective than RSV for boosting a primary immunization with RSV.
    J Virol. 2020 Oct 28. pii: JVI.01512-20. doi: 10.1128/JVI.01512.
    PubMed     Abstract available


  187. GHORBANI A, Abundo MC, Ji H, Taylor KJM, et al
    Viral Subpopulation Screening Guides in Designing a High Interferon Inducing Live Attenuated Influenza Vaccine by Targeting Rare Mutations in NS1 and PB2 Proteins.
    J Virol. 2020 Oct 28. pii: JVI.01722-20. doi: 10.1128/JVI.01722.
    PubMed     Abstract available


  188. COOK PW, Stark T, Jones J, Kondor R, et al
    Detection and Characterization of Swine-origin Influenza A(H1N1) Pandemic 2009 Viruses in Humans Following Zoonotic Transmission.
    J Virol. 2020 Oct 28. pii: JVI.01066-20. doi: 10.1128/JVI.01066.
    PubMed     Abstract available


  189. RENEER ZB, Jamieson PJ, Skarlupka AL, Huang Y, et al
    Computationally Optimized Broadly Reactive H2 HA Influenza Vaccines Elicited Broadly Cross-Reactive Antibodies and Protected Mice from Viral Challenges.
    J Virol. 2020 Oct 28. pii: JVI.01526-20. doi: 10.1128/JVI.01526.
    PubMed     Abstract available


  190. JOBE F, Simpson J, Hawes P, Guzman E, et al
    Respiratory Syncytial Virus Sequesters NF-kappaB Subunit p65 to Cytoplasmic Inclusion Bodies To Inhibit Innate Immune Signaling.
    J Virol. 2020;94.
    PubMed     Abstract available


  191. GAO Q, Yang C, Ren C, Zhang S, et al
    Eukaryotic translation elongation factor 1 delta inhibits the nuclear import of nucleoprotein and PA-PB1 heterodimer of influenza A virus.
    J Virol. 2020 Oct 21. pii: JVI.01391-20. doi: 10.1128/JVI.01391.
    PubMed     Abstract available


  192. MANZOOR R, Eguchi N, Yoshida R, Ozaki H, et al
    A novel mechanism underlying antiviral activity of an influenza virus M2-specific antibody.
    J Virol. 2020 Oct 14. pii: JVI.01277-20. doi: 10.1128/JVI.01277.
    PubMed     Abstract available


  193. JEONG JH, Choi WS, Antigua KJC, Choi YK, et al
    In vitro profiling of laninamivir-resistant substitutions in N3 to N9 avian influenza neuraminidase subtypes and their association with in vivo susceptibility.
    J Virol. 2020 Oct 14. pii: JVI.01679-20. doi: 10.1128/JVI.01679.
    PubMed     Abstract available


  194. MATSUYAMA S, Kawase M, Nao N, Shirato K, et al
    The inhaled steroid ciclesonide blocks SARS-CoV-2 RNA replication by targeting the viral replication-transcription complex in cultured cells.
    J Virol. 2020 Oct 14. pii: JVI.01648-20. doi: 10.1128/JVI.01648.
    PubMed     Abstract available


  195. LI Z, Qu X, Liu X, Huan C, et al
    GBP5 Is an Interferon-Induced Inhibitor of Respiratory Syncytial Virus.
    J Virol. 2020;94.
    PubMed     Abstract available


  196. ARAI Y, Kawashita N, Elgendy EM, Ibrahim MS, et al
    PA mutations inherited during viral evolution act cooperatively to increase replication of contemporary H5N1 influenza virus with an expanded host range.
    J Virol. 2020 Oct 7. pii: JVI.01582-20. doi: 10.1128/JVI.01582.
    PubMed     Abstract available


  197. WEI Y, Zeng Y, Zhang X, Xu S, et al
    The Nucleoprotein of H7N9 Influenza Virus Positively Regulates TRAF3-Mediated Innate Signaling and Attenuates Viral Virulence in Mice.
    J Virol. 2020 Oct 7. pii: JVI.01640-20. doi: 10.1128/JVI.01640.
    PubMed     Abstract available


    September 2020
  198. CRIADO MF, Sa E Silva M, Lee DH, de Lima Salge CA, et al
    Cross-protection by inactivated H5 pre-pandemic vaccine seed strains against diverse Goose/Guangdong lineage H5N1 highly pathogenic avian influenza viruses.
    J Virol. 2020 Sep 30. pii: JVI.00720-20. doi: 10.1128/JVI.00720.
    PubMed     Abstract available


  199. NELSON MI, Perofsky A, McBride DS, Rambo-Martin BL, et al
    A heterogenous swine show circuit drives zoonotic transmission of influenza A viruses in the United States.
    J Virol. 2020 Sep 30. pii: JVI.01453-20. doi: 10.1128/JVI.01453.
    PubMed     Abstract available


  200. XUE M, Wang R, Harder O, Chen P, et al
    Stable attenuation of human respiratory syncytial virus for live vaccines by deletion and insertion of amino acids in the hinge region between the mRNA capping and methyltransferase domains of the large polymerase protein.
    J Virol. 2020 Sep 30. pii: JVI.01831-20. doi: 10.1128/JVI.01831.
    PubMed     Abstract available


  201. KINDER JT, Moncman CL, Barrett C, Jin H, et al
    Respiratory Syncytial Virus and Human Metapneumovirus Infections in Three-Dimensional Human Airway Tissues Expose an Interesting Dichotomy in Viral Replication, Spread, and Inhibition by Neutralizing Antibodies.
    J Virol. 2020;94.
    PubMed     Abstract available


  202. MELIOPOULOS V, Cherry S, Wohlgemuth N, Honce R, et al
    Primary swine respiratory epithelial cell lines for the efficient isolation and propagation of influenza A viruses.
    J Virol. 2020 Sep 23. pii: JVI.01091-20. doi: 10.1128/JVI.01091.
    PubMed     Abstract available


  203. ZHANG X, Cunningham FL, Li L, Hanson-Dorr K, et al
    Tissue tropisms of avian influenza A viruses affect their spillovers from wild birds to pigs.
    J Virol. 2020 Sep 23. pii: JVI.00847-20. doi: 10.1128/JVI.00847.
    PubMed     Abstract available


  204. STEINER F, Pavlovic J
    Subcellular localization of MxB determines its antiviral potential against influenza A virus.
    J Virol. 2020 Sep 9. pii: JVI.00125-20. doi: 10.1128/JVI.00125.
    PubMed     Abstract available


  205. SONG J, Sun H, Sun H, Jiang Z, et al
    Swine microRNAs ssc-miR-221-3p and ssc-miR-222 restrict the cross-species infection of avian influenza virus.
    J Virol. 2020 Sep 9. pii: JVI.01700-20. doi: 10.1128/JVI.01700.
    PubMed     Abstract available


  206. EL-SHESHENY R, Franks J, Turner J, Seiler P, et al
    Continued Evolution of H5Nx Avian Influenza Viruses in Bangladeshi Live Poultry Markets: Pathogenic Potential in Poultry and Mammalian Models.
    J Virol. 2020 Sep 9. pii: JVI.01141-20. doi: 10.1128/JVI.01141.
    PubMed     Abstract available


  207. KIRKPATRICK E, Henry C, McMahon M, Jiang K, et al
    Characterization of novel cross-reactive influenza B virus hemagglutinin head specific antibodies that lack hemagglutinin inhibition activity.
    J Virol. 2020 Sep 9. pii: JVI.01185-20. doi: 10.1128/JVI.01185.
    PubMed     Abstract available


  208. BROCATO RL, Principe LM, Kim RK, Zeng X, et al
    Disruption of Adaptive Immunity Enhances Disease in SARS-CoV-2 Infected Syrian Hamsters.
    J Virol. 2020 Sep 8. pii: JVI.01683-20. doi: 10.1128/JVI.01683.
    PubMed     Abstract available


  209. CHIA BS, Li B, Cui A, Eisenhaure T, et al
    Loss of the nuclear protein RTF2 enhances influenza replication.
    J Virol. 2020 Sep 2. pii: JVI.00319-20. doi: 10.1128/JVI.00319.
    PubMed     Abstract available


    August 2020
  210. BUSSE DC, Habgood-Coote D, Clare S, Brandt C, et al
    Interferon-Induced Protein 44 and Interferon-Induced Protein 44-Like Restrict Replication of Respiratory Syncytial Virus.
    J Virol. 2020;94.
    PubMed     Abstract available


  211. GAO R, Sreenivasan CC, Sheng Z, Hause BM, et al
    Human Monoclonal Antibody Derived from Transchromosomic (Tc) Cattle Neutralizes Multiple H1 Clades of Influenza A Virus by Recognizing a Novel Conformational Epitope in the HA Head Domain.
    J Virol. 2020 Aug 26. pii: JVI.00945-20. doi: 10.1128/JVI.00945.
    PubMed     Abstract available


  212. VIGIL A, Frias-Staheli N, Carabeo T, Wittekind M, et al
    Airway Delivery of Anti-influenza Monoclonal Antibodies Results in Enhanced Anti-Viral Activities and Enables Broad Coverage Combination Therapies.
    J Virol. 2020 Aug 26. pii: JVI.00052-20. doi: 10.1128/JVI.00052.
    PubMed     Abstract available


  213. FROGGATT HM, Heaton BE, Heaton NS
    Development of a fluorescence based, high-throughput SARS-CoV-2 3CL(pro) reporter assay.
    J Virol. 2020 Aug 25. pii: JVI.01265-20. doi: 10.1128/JVI.01265.
    PubMed     Abstract available


  214. DANIELS RS, Tse H, Ermetal B, Xiang Z, et al
    Molecular characterisation of Influenza C viruses from outbreaks in Hong Kong SAR, China.
    J Virol. 2020 Aug 19. pii: JVI.01051-20. doi: 10.1128/JVI.01051.
    PubMed     Abstract available


  215. WESTON S, Coleman CM, Haupt R, Logue J, et al
    Broad anti-coronaviral activity of FDA approved drugs against SARS-CoV-2 in vitro and SARS-CoV in vivo.
    J Virol. 2020 Aug 19. pii: JVI.01218-20. doi: 10.1128/JVI.01218.
    PubMed     Abstract available


  216. WANG Y, Lv Y, Niu X, Dong J, et al
    L226Q mutation on influenza H7N9 virus hemagglutinin increases receptor-binding avidity and leads to biased antigenicity evaluation.
    J Virol. 2020 Aug 12. pii: JVI.00667-20. doi: 10.1128/JVI.00667.
    PubMed     Abstract available


  217. JOHNSON MC, Lyddon TD, Suarez R, Salcedo B, et al
    Optimized pseudotyping conditions for the SARS COV-2 Spike glycoprotein.
    J Virol. 2020 Aug 11. pii: JVI.01062-20. doi: 10.1128/JVI.01062.
    PubMed     Abstract available


    July 2020
  218. KAPLAN BS, Kimble JB, Chang J, Anderson TK, et al
    Aerosol Transmission from Infected Swine to Ferrets of an H3N2 Virus Collected from an Agricultural Fair and Associated with Human Variant Infections.
    J Virol. 2020;94.
    PubMed     Abstract available


  219. CLEMENTS AL, Sealy JE, Peacock TP, Sadeyen JR, et al
    Contribution of segment 3 to the acquisition of virulence in contemporary H9N2 avian influenza viruses.
    J Virol. 2020 Jul 29. pii: JVI.01173-20. doi: 10.1128/JVI.01173.
    PubMed     Abstract available


  220. OSTBYE H, Gao J, Rakic Martinez M, Wang H, et al
    N-linked glycan sites on the influenza NA head domain are required for efficient IAV incorporation and replication.
    J Virol. 2020 Jul 22. pii: JVI.00874-20. doi: 10.1128/JVI.00874.
    PubMed     Abstract available


  221. CHANG P, Sealy JE, Sadeyen JR, Bhat S, et al
    Immune escape adaptive mutations in the H7N9 avian influenza hemagglutinin protein increase virus replication fitness and decrease pandemic potential.
    J Virol. 2020 Jul 22. pii: JVI.00216-20. doi: 10.1128/JVI.00216.
    PubMed     Abstract available


  222. VANDERHEIDEN A, Ralfs P, Chirkova T, Upadhyay AA, et al
    Type I and Type III IFN Restrict SARS-CoV-2 Infection of Human Airway Epithelial Cultures.
    J Virol. 2020 Jul 22. pii: JVI.00985-20. doi: 10.1128/JVI.00985.
    PubMed     Abstract available


  223. SMITH M, Honce R, Schultz-Cherry S
    Metabolic Syndrome and Viral Pathogenesis: Lessons from Influenza and Coronaviruses.
    J Virol. 2020 Jul 13. pii: JVI.00665-20. doi: 10.1128/JVI.00665.
    PubMed     Abstract available


  224. AHLEN G, Frelin L, Nekoyan N, Weber F, et al
    The SARS-CoV-2 N protein is a good component in a vaccine.
    J Virol. 2020 Jul 13. pii: JVI.01279-20. doi: 10.1128/JVI.01279.
    PubMed     Abstract available


  225. ZHAO X, Chen D, Szabla R, Zheng M, et al
    Broad and differential animal ACE2 receptor usage by SARS-CoV-2.
    J Virol. 2020 Jul 13. pii: JVI.00940-20. doi: 10.1128/JVI.00940.
    PubMed     Abstract available


  226. ARAI Y, Elgendy EM, Daidoji T, Ibrahim MS, et al
    H9N2 influenza virus infections in human cells require a balance between NA sialidase activity and HA receptor affinity.
    J Virol. 2020 Jul 8. pii: JVI.01210-20. doi: 10.1128/JVI.01210.
    PubMed     Abstract available


  227. TABOADA B, Vazquez-Perez JA, Munoz Medina JE, Ramos Cervantes P, et al
    Genomic Analysis of Early SARS-CoV-2 Variants Introduced in Mexico.
    J Virol. 2020 Jul 8. pii: JVI.01056-20. doi: 10.1128/JVI.01056.
    PubMed     Abstract available


  228. ZHAO X, Zheng S, Chen D, Zheng M, et al
    LY6E Restricts the Entry of Human Coronaviruses, Including the Currently Pandemic SARS-CoV-2.
    J Virol. 2020 Jul 8. pii: JVI.00562-20. doi: 10.1128/JVI.00562.
    PubMed     Abstract available


  229. BELSER JA, Sun X, Brock N, Pappas C, et al
    Genetically and antigenically divergent influenza A(H9N2) viruses exhibit differential replication and transmission phenotypes in mammalian models.
    J Virol. 2020 Jul 1. pii: JVI.00451-20. doi: 10.1128/JVI.00451.
    PubMed     Abstract available


  230. WAN XF, Ferguson L, Oliva J, Rubrum A, et al
    Limited cross-protection provided by prior infection contributes to high prevalence of influenza D viruses in cattle.
    J Virol. 2020 Jul 1. pii: JVI.00240-20. doi: 10.1128/JVI.00240.
    PubMed     Abstract available


    June 2020
  231. MOORE JP, Klasse PJ
    SARS-CoV-2 vaccines: 'Warp Speed' needs mind melds not warped minds.
    J Virol. 2020 Jun 26. pii: JVI.01083-20. doi: 10.1128/JVI.01083.
    PubMed     Abstract available


  232. LIU Z, Zheng H, Lin H, Li M, et al
    Identification of common deletions in the spike protein of SARS-CoV-2.
    J Virol. 2020 Jun 22. pii: JVI.00790-20. doi: 10.1128/JVI.00790.
    PubMed     Abstract available


  233. DENG X, Buckley AC, Pillatzki A, Lager KM, et al
    Inactivating Three Interferon Antagonists Attenuates Pathogenesis of an Enteric Coronavirus.
    J Virol. 2020 Jun 17. pii: JVI.00565-20. doi: 10.1128/JVI.00565.
    PubMed     Abstract available


  234. XU C, Xu B, Wu Y, Yang S, et al
    Erratum for Xu et al., "A Single Amino Acid at Position 431 of the PB2 Protein Determines the Virulence of H1N1 Swine Influenza Viruses in Mice".
    J Virol. 2020;94.
    PubMed    


  235. DUTTA NK, Mazumdar K, Gordy JT
    The Nucleocapsid Protein of SARS-CoV-2: a Target for Vaccine Development.
    J Virol. 2020;94.
    PubMed    


  236. GHAFARI M, Lumby CK, Weissman DB, Illingworth CJR, et al
    Inferring Transmission Bottleneck Size from Viral Sequence Data Using a Novel Haplotype Reconstruction Method.
    J Virol. 2020;94.
    PubMed     Abstract available


  237. DENG Y, Herbert JA, Robinson E, Ren L, et al
    Neutrophil-Airway Epithelial Interactions Result in Increased Epithelial Damage and Viral Clearance during Respiratory Syncytial Virus Infection.
    J Virol. 2020;94.
    PubMed     Abstract available


  238. ZHENG A, Sun W, Xiong X, Freyn AW, et al
    Enhancing Neuraminidase Immunogenicity of Influenza A Viruses by Rewiring RNA Packaging Signals.
    J Virol. 2020 Jun 3. pii: JVI.00742-20. doi: 10.1128/JVI.00742.
    PubMed     Abstract available


    May 2020
  239. LIU L, Song S, Shen Y, Ma C, et al
    Truncation of PA-X contributes to virulence and transmission of H3N8 and H3N2 canine influenza viruses in dogs.
    J Virol. 2020 May 27. pii: JVI.00949-20. doi: 10.1128/JVI.00949.
    PubMed     Abstract available


  240. MILEWSKA A, Kula-Pacurar A, Wadas J, Suder A, et al
    Replication of SARS-CoV-2 in human respiratory epithelium.
    J Virol. 2020 May 20. pii: JVI.00957-20. doi: 10.1128/JVI.00957.
    PubMed     Abstract available


  241. ZHAI X, Sun J, Yan Z, Zhang J, et al
    Comparison of SARS-CoV-2 spike protein binding to ACE2 receptors from human, pets, farm animals, and putative intermediate hosts.
    J Virol. 2020 May 13. pii: JVI.00831-20. doi: 10.1128/JVI.00831.
    PubMed     Abstract available


  242. ZHU Y, Yu D, Yan H, Chong H, et al
    Design of potent membrane fusion inhibitors against SARS-CoV-2, an emerging coronavirus with high fusogenic activity.
    J Virol. 2020 May 6. pii: JVI.00635-20. doi: 10.1128/JVI.00635.
    PubMed     Abstract available


  243. LI J, Li M, Wang X, Sun M, et al
    Long Noncoding RNA NRAV Promotes Respiratory Syncytial Virus Replication by Targeting the MicroRNA miR-509-3p/Rab5c Axis To Regulate Vesicle Transportation.
    J Virol. 2020;94.
    PubMed     Abstract available


  244. HOLLAND LA, Kaelin EA, Maqsood R, Estifanos B, et al
    An 81 nucleotide deletion in SARS-CoV-2 ORF7a identified from sentinel surveillance in Arizona (Jan-Mar 2020).
    J Virol. 2020 May 1. pii: JVI.00711-20. doi: 10.1128/JVI.00711.
    PubMed     Abstract available


    April 2020
  245. MINE J, Uchida Y, Takemae N, Saito T, et al
    Genetic characterization of influenza A viruses in Japanese swine during 2015-2019.
    J Virol. 2020 Apr 29. pii: JVI.02169-19. doi: 10.1128/JVI.02169.
    PubMed     Abstract available


  246. EGGINK D, Spronken M, van der Woude R, Buzink J, et al
    Phenotypic effects of substitutions within the receptor binding site of highly pathogenic avian influenza H5N1 observed during human infection.
    J Virol. 2020 Apr 22. pii: JVI.00195-20. doi: 10.1128/JVI.00195.
    PubMed     Abstract available


  247. VERHAGEN JH, Poen M, Stallknecht DE, van der Vliet S, et al
    Phylogeography and antigenic diversity of low pathogenic avian influenza H13 and H16 viruses.
    J Virol. 2020 Apr 22. pii: JVI.00537-20. doi: 10.1128/JVI.00537.
    PubMed     Abstract available


  248. RAHIM MMA, Parsons BD, Price EL, Slaine PD, et al
    Defective influenza A virus RNA products mediate MAVS-dependent upregulation of human leukocyte antigen class I proteins.
    J Virol. 2020 Apr 22. pii: JVI.00165-20. doi: 10.1128/JVI.00165.
    PubMed     Abstract available


  249. YANG J, Ma C, Zhao Y, Fan A, et al
    Hepatitis B virus core particles containing a conserved region of the G protein combined with interleukin-35 protected mice against respiratory syncytial virus infection without vaccine-enhanced immunopathology.
    J Virol. 2020 Apr 22. pii: JVI.00007-20. doi: 10.1128/JVI.00007.
    PubMed     Abstract available


  250. NGUYEN A, David JK, Maden SK, Wood MA, et al
    Human leukocyte antigen susceptibility map for SARS-CoV-2.
    J Virol. 2020 Apr 17. pii: JVI.00510-20. doi: 10.1128/JVI.00510.
    PubMed     Abstract available


  251. KANDASAMY M, Furlong K, Perez JT, Manicassamy S, et al
    Suppression of Cytotoxic T Cell Functions and Decreased Levels of Tissue-Resident Memory T Cells during H5N1 Infection.
    J Virol. 2020;94.
    PubMed     Abstract available


  252. WIGNALL-FLEMING EB, Vasou A, Young D, Short JAL, et al
    Innate intracellular antiviral responses restrict the amplification of defective virus genomes of Parainfluenza Virus type 5.
    J Virol. 2020 Apr 15. pii: JVI.00246-20. doi: 10.1128/JVI.00246.
    PubMed     Abstract available


  253. WALKER AP, Sharps J, Fodor E
    Mutation of an influenza virus polymerase 3' RNA promoter binding site inhibits transcription elongation.
    J Virol. 2020 Apr 15. pii: JVI.00498-20. doi: 10.1128/JVI.00498.
    PubMed     Abstract available


  254. SHIBUYA M, Aoshi T, Kuroda E, Yoshioka Y, et al
    Murine cross-reactive non-neutralizing polyclonal IgG1 antibodies induced by influenza vaccine inhibit the cross-protective effect of IgG2 against heterologous virus in mice.
    J Virol. 2020 Apr 8. pii: JVI.00323-20. doi: 10.1128/JVI.00323.
    PubMed     Abstract available


  255. PEACOCK TP, Swann OC, Salvesen HA, Staller E, et al
    Swine ANP32A supports avian influenza virus polymerase.
    J Virol. 2020 Apr 8. pii: JVI.00132-20. doi: 10.1128/JVI.00132.
    PubMed     Abstract available


  256. OKUYA K, Yoshida R, Manzoor R, Saito S, et al
    A potential role of non-neutralizing IgA antibodies in cross-protective immunity against influenza A viruses of multiple hemagglutinin subtypes.
    J Virol. 2020 Apr 8. pii: JVI.00408-20. doi: 10.1128/JVI.00408.
    PubMed     Abstract available


  257. WANG M, Li M, Ren R, Li L, et al
    International expansion of a novel SARS-CoV-2 mutant.
    J Virol. 2020 Apr 8. pii: JVI.00567-20. doi: 10.1128/JVI.00567.
    PubMed     Abstract available


  258. VIGEVENO RM, Poen MJ, Parker E, Holwerda M, et al
    Outbreak severity of highly pathogenic avian influenza A(H5N8) viruses is inversely correlated to polymerase complex activity and interferon induction.
    J Virol. 2020 Apr 1. pii: JVI.00375-20. doi: 10.1128/JVI.00375.
    PubMed     Abstract available


  259. LICASTRO D, Rajasekharan S, Dal Monego S, Segat L, et al
    Isolation and full-length genome characterization of SARS-CoV-2 from COVID-19 cases in Northern Italy.
    J Virol. 2020 Apr 1. pii: JVI.00543-20. doi: 10.1128/JVI.00543.
    PubMed     Abstract available


  260. CAGLIANI R, Forni D, Clerici M, Sironi M, et al
    Computational inference of selection underlying the evolution of the novel coronavirus, SARS-CoV-2.
    J Virol. 2020 Apr 1. pii: JVI.00411-20. doi: 10.1128/JVI.00411.
    PubMed     Abstract available


    March 2020
  261. DISKIN ER, Friedman K, Krauss S, Nolting JM, et al
    Subtype diversity of influenza A virus in North American waterfowl: a multi-decade study.
    J Virol. 2020 Mar 18. pii: JVI.02022-19. doi: 10.1128/JVI.02022.
    PubMed     Abstract available


  262. CLOHISEY S, Parkinson N, Wang B, Bertin N, et al
    Comprehensive characterisation of transcriptional activity during influenza A virus infection reveals biases in cap-snatching of host RNA sequences.
    J Virol. 2020 Mar 11. pii: JVI.01720-19. doi: 10.1128/JVI.01720.
    PubMed     Abstract available


  263. SUN Y, Hu Z, Zhang X, Chen M, et al
    R195K mutation in the PA-X protein increases the virulence and transmission of influenza A virus in mammalian hosts.
    J Virol. 2020 Mar 11. pii: JVI.01817-19. doi: 10.1128/JVI.01817.
    PubMed     Abstract available


    February 2020
  264. WANG B, Saito Y, Nishimura M, Ren Z, et al
    An Animal Model That Mimics Human Herpesvirus 6B Pathogenesis.
    J Virol. 2020;94.
    PubMed     Abstract available


  265. FIGUEROA T, Bessiere P, Coggon A, Bouwman KM, et al
    THE MICROBIOTA CONTRIBUTES TO THE CONTROL OF HIGHLY PATHOGENIC H5N9 INFLUENZA VIRUS REPLICATION IN DUCKS.
    J Virol. 2020 Feb 26. pii: JVI.00289-20. doi: 10.1128/JVI.00289.
    PubMed     Abstract available


  266. ISHIDA H, Murakami S, Kamiki H, Matsugo H, et al
    Establishment of a Reverse Genetics System for Influenza D Virus.
    J Virol. 2020 Feb 26. pii: JVI.01767-19. doi: 10.1128/JVI.01767.
    PubMed     Abstract available


  267. FORBESTER JL, Clement M, Wellington D, Yeung A, et al
    IRF5 promotes influenza-induced inflammatory responses in human iPSC-derived myeloid cells and murine models.
    J Virol. 2020 Feb 19. pii: JVI.00121-20. doi: 10.1128/JVI.00121.
    PubMed     Abstract available


  268. CASTRO IA, Jorge DMM, Ferreri LM, Martins RB, et al
    Silent infection of B and CD8(+)T lymphocytes by influenza A virus in children with tonsillar hypertrophy.
    J Virol. 2020 Feb 19. pii: JVI.01969-19. doi: 10.1128/JVI.01969.
    PubMed     Abstract available


  269. BARNARD KN, Alford-Lawrence BK, Buchholz DW, Wasik BR, et al
    Modified sialic acids on mucus and erythrocytes inhibit influenza A HA and NA functions.
    J Virol. 2020 Feb 12. pii: JVI.01567-19. doi: 10.1128/JVI.01567.
    PubMed     Abstract available


  270. BALACHANDRAN S, Rall GF
    The Benefits and Perils of Necroptosis in Influenza Infection.
    J Virol. 2020 Feb 12. pii: JVI.01101-19. doi: 10.1128/JVI.01101.
    PubMed     Abstract available


    January 2020
  271. XU C, Xu B, Wu Y, Yang S, et al
    A single amino acid at position 431 of the PB2 protein determines the virulence of H1N1 swine influenza viruses in mice.
    J Virol. 2020 Jan 29. pii: JVI.01930-19. doi: 10.1128/JVI.01930.
    PubMed     Abstract available


  272. SKARLUPKA AL, Reneer ZB, Abreu RB, Ross TM, et al
    An influenza HA Computationally Optimized Broadly Reactive Antigen elicits antibodies endowed with group-1 heterosubtypic breadth against swine influenza viruses.
    J Virol. 2020 Jan 29. pii: JVI.02061-19. doi: 10.1128/JVI.02061.
    PubMed     Abstract available


  273. WAN Y, Shang J, Graham R, Baric RS, et al
    Receptor recognition by novel coronavirus from Wuhan: An analysis based on decade-long structural studies of SARS.
    J Virol. 2020 Jan 29. pii: JVI.00127-20. doi: 10.1128/JVI.00127.
    PubMed     Abstract available


  274. BEERENS N, Heutink R, Harders F, Bossers A, et al
    Emergence and selection of a highly pathogenic avian influenza H7N3 virus.
    J Virol. 2020 Jan 22. pii: JVI.01818-19. doi: 10.1128/JVI.01818.
    PubMed     Abstract available


  275. WONG SS, Waite B, Ralston J, Wood T, et al
    Hemagglutinin and neuraminidase antibodies are induced in an age- and subtype- dependent manner after influenza virus infection.
    J Virol. 2020 Jan 15. pii: JVI.01385-19. doi: 10.1128/JVI.01385.
    PubMed     Abstract available


  276. PARK JG, Avila-Perez G, Nogales A, Blanco-Lobo P, et al
    Identification and characterization of novel compounds with broad spectrum antiviral activity against influenza A and B viruses.
    J Virol. 2020 Jan 15. pii: JVI.02149-19. doi: 10.1128/JVI.02149.
    PubMed     Abstract available


  277. XIA C, Wolf JJ, Sun C, Xu M, et al
    PARP1 enhances influenza A virus propagation by facilitating degradation of host type I interferon receptor.
    J Virol. 2020 Jan 8. pii: JVI.01572-19. doi: 10.1128/JVI.01572.
    PubMed     Abstract available


  278. LE NOUEN C, Luongo CL, Yang L, Mueller S, et al
    Optimization of the Codon Pair Usage of Human Respiratory Syncytial Virus Paradoxically Resulted in Reduced Viral Replication In Vivo and Reduced Immunogenicity.
    J Virol. 2020;94.
    PubMed     Abstract available


  279. AGGARWAL M, Leser GP, Lamb RA
    Repurposing papaverine as an antiviral agent against influenza viruses and paramyxoviruses.
    J Virol. 2020 Jan 2. pii: JVI.01888-19. doi: 10.1128/JVI.01888.
    PubMed     Abstract available


    December 2019
  280. HUANG Y, Owino SO, Crevar CJ, Carter DM, et al
    N-Linked Glycans and K147 Residue on Hemagglutinin Synergize to Elicit Broadly-Reactive H1N1 Influenza Antibodies.
    J Virol. 2019 Dec 18. pii: JVI.01432-19. doi: 10.1128/JVI.01432.
    PubMed     Abstract available


  281. QIU Y, Stegalkina S, Zhang J, Boudanova E, et al
    Mapping of a Novel H3-Specific Broadly Neutralizing Monoclonal Antibody Targeting the Hemagglutinin Globular Head Isolated from an Elite Influenza Virus-Immunized Donor Exhibiting Serological Breadth.
    J Virol. 2019 Dec 11. pii: JVI.01035-19. doi: 10.1128/JVI.01035.
    PubMed     Abstract available


  282. PARSONS L, An Y, Qi L, White M, et al
    Influenza Hemagglutinins H2, H5, H6, and H11 are not Targets of Pulmonary Surfactant Protein D: N-glycan subtypes in host-pathogen interactions.
    J Virol. 2019 Dec 11. pii: JVI.01951-19. doi: 10.1128/JVI.01951.
    PubMed     Abstract available


  283. VALESANO AL, Fitzsimmons WJ, McCrone JT, Petrie JG, et al
    Influenza B viruses exhibit lower within-host diversity than influenza A viruses in human hosts.
    J Virol. 2019 Dec 4. pii: JVI.01710-19. doi: 10.1128/JVI.01710.
    PubMed     Abstract available


  284. ZHONG G, Fan S, Hatta M, Nakatsu S, et al
    Mutations in the NA-like protein of bat influenza H18N11 virus enhance virus replication in mammalian cells, mice, and ferrets.
    J Virol. 2019 Dec 4. pii: JVI.01416-19. doi: 10.1128/JVI.01416.
    PubMed     Abstract available


    November 2019
  285. OLIVA J, Mettier J, Sedano L, Delverdier M, et al
    A murine model for the study of influenza D virus.
    J Virol. 2019 Nov 27. pii: JVI.01662-19. doi: 10.1128/JVI.01662.
    PubMed     Abstract available


  286. KARAKUS U, Pohl MO, Stertz S
    Breaking the convention: Sialoglycan variants, Co-receptors and Alternative Receptors for Influenza A Virus Entry.
    J Virol. 2019 Nov 27. pii: JVI.01357-19. doi: 10.1128/JVI.01357.
    PubMed     Abstract available


  287. RODRIGUEZ-FRANDSEN A, Martin-Sancho L, Gounder AP, Chang MW, et al
    Viral determinants in H5N1 influenza A virus enable productive infection of HeLa cells.
    J Virol. 2019 Nov 27. pii: JVI.01410-19. doi: 10.1128/JVI.01410.
    PubMed     Abstract available


  288. SMITH A, Rodriguez L, Ghouayel ME, Nogales A, et al
    A live-attenuated influenza vaccine (LAIV) elicits enhanced heterologous protection when the internal genes of the vaccine are matched to the challenge virus.
    J Virol. 2019 Nov 20. pii: JVI.01065-19. doi: 10.1128/JVI.01065.
    PubMed     Abstract available


  289. RIJAL P, Wang BB, Tan TK, Schimanski L, et al
    Broadly inhibiting anti-neuraminidase monoclonal antibodies induced by trivalent influenza vaccine and H7N9 infection in humans.
    J Virol. 2019 Nov 20. pii: JVI.01182-19. doi: 10.1128/JVI.01182.
    PubMed     Abstract available


  290. MISTRY B, Long JS, Schreyer J, Staller E, et al
    Elucidating the interactions between influenza virus polymerase and host factor ANP32A.
    J Virol. 2019 Nov 6. pii: JVI.01353-19. doi: 10.1128/JVI.01353.
    PubMed     Abstract available


  291. WANG G, Jiang L, Wang J, Zhang J, et al
    The G protein-coupled receptor FFAR2 promotes internalization during influenza A virus entry.
    J Virol. 2019 Nov 6. pii: JVI.01707-19. doi: 10.1128/JVI.01707.
    PubMed     Abstract available


  292. RUSSIER M, Yang G, Briard B, Meliopoulos V, et al
    HA stability regulates H1N1 influenza virus replication and pathogenicity in mice by modulating type I interferon responses in dendritic cells.
    J Virol. 2019 Nov 6. pii: JVI.01423-19. doi: 10.1128/JVI.01423.
    PubMed     Abstract available


  293. HU B, Siche S, Moller L, Veit M, et al
    Amphipathic helices of cellular proteins can replace the helix in M2 of Influenza A virus with only small effects on virus replication.
    J Virol. 2019 Nov 6. pii: JVI.01605-19. doi: 10.1128/JVI.01605.
    PubMed     Abstract available


    October 2019
  294. KONG H, Ma S, Wang J, Gu C, et al
    Identification of key amino acids in the PB2 and M1 proteins of H7N9 influenza virus that affect its transmission in guinea pigs.
    J Virol. 2019 Oct 9. pii: JVI.01180-19. doi: 10.1128/JVI.01180.
    PubMed     Abstract available


  295. MONTEAGUDO PL, Munoz-Moreno R, Fribourg M, Potla U, et al
    Differential modulation of innate immune responses in human primary cells by influenza A viruses carrying human or avian non-structural 1 proteins.
    J Virol. 2019 Oct 9. pii: JVI.00999-19. doi: 10.1128/JVI.00999.
    PubMed     Abstract available


  296. HENSEN L, Matrosovich T, Roth K, Klenk HD, et al
    Hemagglutinin-dependent tropism of H5N1 and H7N9 influenza viruses to human endothelial cells is determined by reduced stability of the HA which allows the virus to cope with inefficient endosomal acidification and constitutively expressed IFITM3.
    J Virol. 2019 Oct 9. pii: JVI.01223-19. doi: 10.1128/JVI.01223.
    PubMed     Abstract available


  297. LAPORTE M, Stevaert A, Raeymaekers V, Boogaerts T, et al
    Hemagglutinin cleavability, acid-stability and temperature dependence optimize influenza B virus for replication in human airways.
    J Virol. 2019 Oct 9. pii: JVI.01430-19. doi: 10.1128/JVI.01430.
    PubMed     Abstract available


    September 2019
  298. BLANCO JCG, Fernando LR, Zhang W, Kamali A, et al
    Alternative Virus-Like Particle-Associated Pre-Fusion F Proteins as Maternal Vaccines for Respiratory Syncytial Virus.
    J Virol. 2019 Sep 11. pii: JVI.00914-19. doi: 10.1128/JVI.00914.
    PubMed     Abstract available


    May 2019
  299. HUANG S, Zhu B, Cheon IS, Goplen NP, et al
    PPAR-gamma in Macrophages Limits Pulmonary Inflammation and Promotes Host Recovery following Respiratory Viral Infection.
    J Virol. 2019;93.
    PubMed     Abstract available


  300. MCGINNES CULLEN L, Schmidt MR, Morrison TG
    Effect of Previous Respiratory Syncytial Virus Infection on Murine Immune Responses to F and G Protein-Containing Virus-Like Particles.
    J Virol. 2019;93.
    PubMed     Abstract available


    February 2019
  301. JORQUERA PA, Mathew C, Pickens J, Williams C, et al
    Verdinexor (KPT-335), a Selective Inhibitor of Nuclear Export, Reduces Respiratory Syncytial Virus Replication In Vitro.
    J Virol. 2019;93.
    PubMed     Abstract available


    January 2019
  302. MANLEY GCA, Stokes CA, Marsh EK, Sabroe I, et al
    DUSP10 Negatively Regulates the Inflammatory Response to Rhinovirus through Interleukin-1beta Signaling.
    J Virol. 2019;93.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Influenza is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: